| Name | Xamoterol |
|---|---|
| Synonyms |
XAMOTEROL FUMARATE
N-(2-((2-hydroxy-3-(4-hydroxyphenoxy)propyl)amino)ethyl)-4-morpholinecarboxamide |
| Description | Xamoterol is a selective and potent agonist of beta1-adrenergic receptor. Xamoterol has the potential for the research of arrhythmogenesis. Xamoterol has the potential for the investigating the relationship between β1-adrenergic stimulation and IKr[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.265g/cm3 |
|---|---|
| Boiling Point | 651.4ºC at 760 mmHg |
| Molecular Formula | C20H29N3O9 |
| Molecular Weight | 455.45900 |
| Flash Point | 347.7ºC |
| Exact Mass | 455.19000 |
| PSA | 177.89000 |
| LogP | 0.19480 |
| Appearance | solid | white |
| Index of Refraction | 1.571 |
| Water Solubility | H2O: 10 mg/mL at 60 °C, soluble |
| Safety Phrases | 22-24/25 |
|---|---|
| WGK Germany | 3 |
|
~%
81801-12-9 |
| Literature: Barlow; Main; Snow Journal of Medicinal Chemistry, 1981 , vol. 24, # 3 p. 315 - 322 |
|
~%
81801-12-9 |
| Literature: Barlow; Main; Snow Journal of Medicinal Chemistry, 1981 , vol. 24, # 3 p. 315 - 322 |
|
~%
81801-12-9 |
| Literature: Barlow; Main; Snow Journal of Medicinal Chemistry, 1981 , vol. 24, # 3 p. 315 - 322 |
| Precursor 2 | |
|---|---|
| DownStream 0 | |